亚洲视频免费一区,国产欧美综合一区二区,亚洲国产观看,91精品啪在线观看国产91九色,日本又黄又粗暴的gif动态图含羞,麻豆国产一区二区在线观看,中文字幕在线二区

   
 
China revokes patent on Gilead AIDS drug over pricing
(Pharmalive)
Updated: 2013-08-12

China revokes patent on Gilead AIDS drug over pricing

In the latest row between global drugmakers and governments over affordable medicines, China’s State Intellectual Property Office revoked the patent on Viread, a drug sold by Gilead Sciences for treating HIV/AIDS and hepatitis B, after a challenge by Aurisco, the largest manufacturer of active pharmaceutical ingredients in the Asian country. It is said that the rational for the move was that the Viread patent lacked novelty and was not entitled to protection. And in this instance, the decision means that, unlike when a government issues a compulsory license to a specific patent challenger, the Chinese market for Viread will now be opened to numerous competitors.



The J-Innovation

Steve Jobs died the month that the latest Nobel Prize winners were announced. The coincidence lends itself to speculation about inevitability.

Volunteer team bails out busy court

Government supports unique intellectual property fund

IP service providers showcase products

Experts call for standardization of IP services